Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.
2.

Vaccination for pandemic influenza: a six point agenda for interpandemic years.

Fedson DS.

Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S74-7. Review.

PMID:
14730273
3.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
4.

Pandemic vaccines: promises and pitfalls.

Booy R, Brown LE, Grohmann GS, Macintyre CR.

Med J Aust. 2006 Nov 20;185(10 Suppl):S62-5. Review.

PMID:
17115955
5.

Pandemic influenza: overview of vaccines and antiviral drugs.

Cox MM.

Yale J Biol Med. 2005 Oct;78(5):321-8. Review.

6.

Influenza vaccine supply: building long-term sustainability.

Hehme N, Colegate T, Palache B, Hessel L.

Vaccine. 2008 Sep 12;26 Suppl 4:D23-6. Review.

PMID:
19230154
7.

Strategies for broad global access to pandemic influenza vaccines.

Edwards KM, Sabow A, Pasternak A, Boslego JW.

Curr Top Microbiol Immunol. 2009;333:471-93. doi: 10.1007/978-3-540-92165-3_23. Review.

PMID:
19768420
8.

Preparing for pandemic influenza: revisit the basics.

Chan WF, Wong TK.

J Clin Nurs. 2007 Oct;16(10):1858-64. Review.

PMID:
17880474
9.

Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy.

Daems R, Del Giudice G, Rappuoli R.

Vaccine. 2005 Dec 30;23(50):5732-42. Epub 2005 Oct 18. Review.

PMID:
16271423
10.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

PMID:
18948744
11.
12.

Progress with human H5N1 vaccines: a perspective from industry.

Palache B, Krause R.

Expert Rev Vaccines. 2009 Apr;8(4):391-400. doi: 10.1586/erv.09.16. Review.

PMID:
19348556
13.

[Influenza, an existing public health problem].

García-García J, Ramos C.

Salud Publica Mex. 2006 May-Jun;48(3):244-67. Review. Spanish.

14.

Prioritization of pandemic influenza vaccine: rationale and strategy for decision making.

Schwartz B, Orenstein WA.

Curr Top Microbiol Immunol. 2009;333:495-507. doi: 10.1007/978-3-540-92165-3_24. Review.

PMID:
19768421
15.

Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.

O'Neill E, Donis RO.

Curr Top Microbiol Immunol. 2009;333:83-108. doi: 10.1007/978-3-540-92165-3_4. Review.

PMID:
19768401
16.

Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.

Hasegawa H, Ichinohe T, Tamura S, Kurata T.

Expert Rev Vaccines. 2007 Apr;6(2):193-201. Review.

PMID:
17408369
17.

Current status and progress of prepandemic and pandemic influenza vaccine development.

Leroux-Roels I, Leroux-Roels G.

Expert Rev Vaccines. 2009 Apr;8(4):401-23. doi: 10.1586/erv.09.15. Review.

PMID:
19348557
18.

Designing vaccines for pandemic influenza.

Horimoto T, Kawaoka Y.

Curr Top Microbiol Immunol. 2009;333:165-76. doi: 10.1007/978-3-540-92165-3_8. Review.

PMID:
19768405
19.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Perdue ML, Bright RA.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk